Abbott has announced the international launch of its everolimus-eluting coronary stent system [Xience V].

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1559, 2006-01, pp. : 23-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cordis Corporation has announced the launch of its third-generation sirolimus-eluting coronary stent, Cypher Select Plus.

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Everolimus-eluting stent for prevention of restenosis

Inpharma, Vol. 1, Iss. 1441, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Everolimus-eluting stent superior: the SPIRIT III trial

Inpharma, Vol. 1, Iss. 1585, 2007-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Everolimus-eluting stent edges ahead?

Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

7-Hexanoyltaxol-eluting coronary stent has risky benefit

Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite